Clinical Trials: Source Data Review Remotely

Process Flow for Remote Source Data Review – Inspection Readiness Guide

Posted on digi By digi

Remote Source Data Review (SDR) refers to the centralized or off-site evaluation of source records to assess data quality, protocol compliance, and patient safety in clinical trials. Unlike traditional Source Data Verification (SDV), which involves checking CRFs against source at the site, SDR focuses on reviewing narrative, unstructured, or source data—either pre-transcribed or directly accessible via eSource platforms.
Click to read the full article.

Remote Monitoring and Virtual Visits, Source Data Review Remotely

FDA-Ready Guide – eSource vs. Scanned Source Documents

Posted on digi By digi

Remote source data review (SDR) relies heavily on how source documents are made available to monitors. In the evolving regulatory landscape, two primary formats dominate: electronic source (eSource) and scanned source documents. While both are used to support remote oversight, they differ significantly in terms of validation, traceability, regulatory expectations, and operational efficiency.
Click to read the full article.

Remote Monitoring and Virtual Visits, Source Data Review Remotely

FDA-Ready Guide – Audit Trails in Remote SDR Platforms

Posted on digi By digi

As decentralized and hybrid trials increasingly rely on remote source data review (SDR), regulators are turning their attention to one critical component: the audit trail. Whether SDR is conducted via eSource platforms, scanned portals, or remote EMR viewers, the ability to track who accessed what data, when, and what action was taken is essential for demonstrating oversight and compliance.
Click to read the full article.

Remote Monitoring and Virtual Visits, Source Data Review Remotely

How to Achieve Validating Remote SDR Tools for Compliance with FDA/EMA Oversight

Posted on digi By digi

As clinical trials increasingly rely on remote source data review (SDR) platforms for centralized monitoring, regulators are scrutinizing whether these tools meet Good Clinical Practice (GCP) standards. Remote SDR tools are not just operational conveniences—they’re systems used in making decisions that directly impact data integrity, subject safety, and protocol compliance. As such, they are subject to validation under GxP requirements.
Click to read the full article.

Remote Monitoring and Virtual Visits, Source Data Review Remotely

How to Document Remote SDR Activities in the TMF for Inspection Readiness

Posted on digi By digi

As remote Source Data Review (SDR) becomes increasingly common in decentralized and hybrid clinical trials, regulators expect clear, structured documentation of these activities. SDR is more than a monitoring convenience—it is a formal oversight process that must be traceable, justified, and fully integrated into the Trial Master File (TMF).
Click to read the full article.

Remote Monitoring and Virtual Visits, Source Data Review Remotely

FDA-Ready Guide – Documenting SDR Reviewer Activity and Oversight

Posted on digi By digi

In decentralized clinical trials, Source Data Review (SDR) is often conducted remotely through centralized monitoring platforms, eSource access, or scanned document portals. While sponsors and CROs focus on capturing alerts and deviations, regulators also expect clear documentation of who reviewed the data, when the review occurred, what was reviewed, and what decisions or actions were taken.
Click to read the full article.

Remote Monitoring and Virtual Visits, Source Data Review Remotely

How to Log and Document SDR Findings and Annotations for Compliance

Posted on digi By digi

In remote monitoring setups, the effectiveness of Source Data Review (SDR) is directly linked to how findings are documented. SDR involves reviewing source data—either electronically or through scanned uploads—to identify inconsistencies, missing information, and potential protocol deviations. But unless these observations are logged, categorized, and traceable, they hold little regulatory value.
Click to read the full article.

Remote Monitoring and Virtual Visits, Source Data Review Remotely

How to Generate SDR Summary Reports and Dashboards for Oversight

Posted on digi By digi

Source Data Review (SDR) is a critical aspect of centralized monitoring in decentralized and hybrid clinical trials. However, reviewing source documents remotely is only half the process. Sponsors and CROs must also aggregate and report SDR outcomes to demonstrate oversight, identify risks, and drive corrective actions. This is achieved through SDR Summary Reports and Dashboards.
Click to read the full article.

Remote Monitoring and Virtual Visits, Source Data Review Remotely

How to Link SDR Findings to CAPA and Manage Deviation Responses

Posted on digi By digi

As centralized monitoring becomes a regulatory norm, sponsors are under increased pressure to not only identify data issues through Source Data Review (SDR), but also to act on those findings via Corrective and Preventive Actions (CAPA) and deviation response workflows. Without this linkage, SDR can appear passive—undermining its value in risk-based monitoring and inspection defense.
Click to read the full article.

Remote Monitoring and Virtual Visits, Source Data Review Remotely

How to Prepare for Audits Involving Remote SDR and Centralized Review

Posted on digi By digi

Remote Source Data Review (SDR) has become a key strategy for maintaining clinical trial oversight in decentralized and hybrid models. While effective, it introduces new regulatory expectations—particularly around documentation, reviewer accountability, and traceability of oversight actions. Consequently, auditors from regulatory agencies such as the FDA, EMA, and MHRA are placing increasing scrutiny on centralized monitoring activities during Good Clinical Practice (GCP) inspections.
Click to read the full article.

Remote Monitoring and Virtual Visits, Source Data Review Remotely